← Back to Search

Ultrasound

Ultrasound Frequency for Fetal Growth Abnormalities (SUN Trial)

N/A

Waitlist Available

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Maternal age ≥ 18 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 72 hours after delivery

Awards & highlights

SUN Trial Summary

This trial is testing how often fetal growth abnormalities are diagnosed when ultrasound is done every 2 weeks versus every 4 weeks.

Who is the study for?

This trial is for pregnant individuals over 18 with high-risk single-baby pregnancies, needing regular fetal growth checks. They must have had an early pregnancy ultrasound or know their conception date from IVF, be between 20 and nearly 28 weeks along, and have insurance.Check my eligibility

What is being tested?

The study is looking at how often fetal growth issues are found when using ultrasounds every two weeks compared to every four weeks in high-risk pregnancies. It's a randomized controlled trial which means participants are randomly assigned to one of the two schedules.See study design

What are the potential side effects?

Ultrasound is generally considered safe but can sometimes cause mild discomfort during the procedure. There are no significant side effects associated with its use for monitoring fetal development.

SUN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

SUN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 72 hours after delivery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 72 hours after delivery

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 72 hours after delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Frequency of detection of fetal growth abnormalities, starting at 28 weeks gestational age

Secondary outcome measures

Birthweight compared to antenatal estimated fetal weights

Composite maternal morbidity (CMM)

Composite neonatal morbidity (CNM)

+2 more

SUN Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Fetal growth ultrasound every 2 weeksExperimental Treatment1 Intervention

Ultrasound to measure fetal growth every 2 weeks (i.e. 28, 30, 32, 34, 36, 38 weeks gestation).

Group II: Fetal growth ultrasound every 4 weeksActive Control1 Intervention

Ultrasound to measure fetal growth every 4 weeks (i.e. 28, 32 and 36 weeks gestation). Usual Care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ultrasound

2013

Completed Phase 1

~1950

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

320,749 Total Patients Enrolled

Media Library

Ultrasound (Ultrasound) Clinical Trial Eligibility Overview. Trial Name: NCT02719886 — N/A

Interval Growth Ultrasound Research Study Groups: Fetal growth ultrasound every 2 weeks, Fetal growth ultrasound every 4 weeks

Interval Growth Ultrasound Clinical Trial 2023: Ultrasound Highlights & Side Effects. Trial Name: NCT02719886 — N/A

Ultrasound (Ultrasound) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02719886 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical experiment permit elderly individuals to participate?

"In accordance with the study's requirements, all participants must be aged between 18 and 50."

Answered by AI

Could I be a candidate for this trial based on my medical profile?

"This medical trial is enlisting 228 individuals aged 18-50 who have undergone interval growth ultrasound. Along with this, aspiring participants must meet the following requisites: high-risk pregnancy necessitating routine fetal development checkup as directed by their doctor; singleton pregnancies; gestational age of ≥ 20 weeks to 27 weeks 6 days; possess insurance coverage (private or public); gestation period determined by ultrasound ≤ 21 weeks and 6 days or known date of conception resulting from in vitro fertilization treatment methods; no major anomalies present."

Answered by AI

Are there any vacancies available to partake in this clinical trial?

"The clinical trial, listed on clinicaltrials.gov since April 1st 2016 and having last been updated in December 8th of the same year, is not currently recruiting participants. Nonetheless, there are other studies taking place at present that require applicants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Timing of Serial Ultrasounds

Robyn Roberts 2016. "Timing of Serial Ultrasounds". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02719886.